Medical technology company Integer Holdings (NYSE:ITGR) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Integer Holdings beat analysts’ revenue expectations by 0.6% last quarter, reporting revenues of $449.5 million, up 11.1% year on year. It was a mixed quarter for the company, with full-year revenue guidance slightly topping analysts’ expectations but a miss of analysts’ EPS estimates.

Is Integer Holdings a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Integer Holdings’s revenue to grow 5.1% year on year to $428.7 million, slowing from the 11.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.24 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Integer Holdings has missed Wall Street’s revenue estimates four times over the last two years.

Looking at Integer Holdings’s peers in the healthcare equipment and supplies segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Intuitive Surgical delivered year-on-year revenue growth of 19.2%, beating analysts’ expectations by 3.1%, and Boston Scientific reported revenues up 20.9%, topping estimates by 2%.

Read our full analysis of Intuitive Surgical’s results here and Boston Scientific’s results here.

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. We prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.